skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Title: Predicting 5‐year dementia conversion in veterans with mild cognitive impairment
Abstract INTRODUCTIONIdentifying mild cognitive impairment (MCI) patients at risk for dementia could facilitate early interventions. Using electronic health records (EHRs), we developed a model to predict MCI to all‐cause dementia (ACD) conversion at 5 years. METHODSCox proportional hazards model was used to identify predictors of ACD conversion from EHR data in veterans with MCI. Model performance (area under the receiver operating characteristic curve [AUC] and Brier score) was evaluated on a held‐out data subset. RESULTSOf 59,782 MCI patients, 15,420 (25.8%) converted to ACD. The model had good discriminative performance (AUC 0.73 [95% confidence interval (CI) 0.72–0.74]), and calibration (Brier score 0.18 [95% CI 0.17–0.18]). Age, stroke, cerebrovascular disease, myocardial infarction, hypertension, and diabetes were risk factors, while body mass index, alcohol abuse, and sleep apnea were protective factors. DISCUSSIONEHR‐based prediction model had good performance in identifying 5‐year MCI to ACD conversion and has potential to assist triaging of at‐risk patients. HighlightsOf 59,782 veterans with mild cognitive impairment (MCI), 15,420 (25.8%) converted to all‐cause dementia within 5 years.Electronic health record prediction models demonstrated good performance (area under the receiver operating characteristic curve 0.73; Brier 0.18).Age and vascular‐related morbidities were predictors of dementia conversion.Synthetic data was comparable to real data in modeling MCI to dementia conversion. Key PointsAn electronic health record–based model using demographic and co‐morbidity data had good performance in identifying veterans who convert from mild cognitive impairment (MCI) to all‐cause dementia (ACD) within 5 years.Increased age, stroke, cerebrovascular disease, myocardial infarction, hypertension, and diabetes were risk factors for 5‐year conversion from MCI to ACD.High body mass index, alcohol abuse, and sleep apnea were protective factors for 5‐year conversion from MCI to ACD.Models using synthetic data, analogs of real patient data that retain the distribution, density, and covariance between variables of real patient data but are not attributable to any specific patient, performed just as well as models using real patient data. This could have significant implications in facilitating widely distributed computing of health‐care data with minimized patient privacy concern that could accelerate scientific discoveries.  more » « less
Award ID(s):
2124127
PAR ID:
10497313
Author(s) / Creator(s):
 ;  ;  ;  ;  ;  ;  ;  
Publisher / Repository:
Wiley Blackwell (John Wiley & Sons)
Date Published:
Journal Name:
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Volume:
16
Issue:
1
ISSN:
2352-8729
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Abstract INTRODUCTIONIdentification of individuals with mild cognitive impairment (MCI) who are at risk of developing Alzheimer's disease (AD) is crucial for early intervention and selection of clinical trials. METHODSWe applied natural language processing techniques along with machine learning methods to develop a method for automated prediction of progression to AD within 6 years using speech. The study design was evaluated on the neuropsychological test interviews ofn = 166 participants from the Framingham Heart Study, comprising 90 progressive MCI and 76 stable MCI cases. RESULTSOur best models, which used features generated from speech data, as well as age, sex, and education level, achieved an accuracy of 78.5% and a sensitivity of 81.1% to predict MCI‐to‐AD progression within 6 years. DISCUSSIONThe proposed method offers a fully automated procedure, providing an opportunity to develop an inexpensive, broadly accessible, and easy‐to‐administer screening tool for MCI‐to‐AD progression prediction, facilitating development of remote assessment. HighlightsVoice recordings from neuropsychological exams coupled with basic demographics can lead to strong predictive models of progression to dementia from mild cognitive impairment.The study leveraged AI methods for speech recognition and processed the resulting text using language models.The developed AI‐powered pipeline can lead to fully automated assessment that could enable remote and cost‐effective screening and prognosis for Alzehimer's disease. 
    more » « less
  2. Abstract IntroductionAutomated computational assessment of neuropsychological tests would enable widespread, cost‐effective screening for dementia. MethodsA novel natural language processing approach is developed and validated to identify different stages of dementia based on automated transcription of digital voice recordings of subjects’ neuropsychological tests conducted by the Framingham Heart Study (n= 1084). Transcribed sentences from the test were encoded into quantitative data and several models were trained and tested using these data and the participants’ demographic characteristics. ResultsAverage area under the curve (AUC) on the held‐out test data reached 92.6%, 88.0%, and 74.4% for differentiating Normal cognition from Dementia, Normal or Mild Cognitive Impairment (MCI) from Dementia, and Normal from MCI, respectively. DiscussionThe proposed approach offers a fully automated identification of MCI and dementia based on a recorded neuropsychological test, providing an opportunity to develop a remote screening tool that could be adapted easily to any language. 
    more » « less
  3. Abstract INTRODUCTIONOlder adults represent the fastest growing segment of the homeless community. Little is known about the prevalence of dementia and mild cognitive impairment (MCI) in this population. METHODSDementia and MCI screening using the Montreal Cognitive Assessment (MoCA) was incorporated into the standard senior evaluation for adult clients aged ≥ 55 in a large emergency homeless shelter. RESULTSIn a 6‐week period, 104 of 112 (92.9%) assessments were positive for dementia or MCI using a standard cutoff of 26, and 81 (72.3%) were positive using a conservative cutoff of 23. There was no significant difference in MoCA scores based on sex or education level, and no significant correlation between age and MoCA score. DISCUSSIONOlder adults experiencing homelessness may have a high likelihood of dementia or MCI. Routine MoCA screening in older adults experiencing homelessness is feasible and can help to identify services needed to successfully exit homelessness. 
    more » « less
  4. :Diabetes has been linked to an increased risk of mild cognitive impairment (MCI), a conditioncharacterized by a subtle cognitive decline that may precede the development of dementia. Theunderlying mechanisms connecting diabetes and MCI involve complex interactions between metabolicdysregulation, inflammation, and neurodegeneration. A critical mechanism implicated in diabetes andMCI is the activation of inflammatory pathways. Chronic low-grade inflammation, as observed in diabetes,can lead to the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha(TNF-α), interleukin-6 (IL-6), interleukin-1 beta (IL-1β), and interferon-gamma (IFNγ), each of whichcan exacerbate neuroinflammation and contribute to cognitive decline. A crucial enzyme involved inregulating inflammation is ADAM17, a disintegrin, and metalloproteinase, which can cleave and releaseTNF-α from its membrane-bound precursor and cause it to become activated. These processes, inturn, activate additional inflammation-related pathways, such as AKT, NF-κB, NLP3, MAPK, andJAK-STAT pathways. Recent research has provided novel insights into the role of ADAM17 in diabetesand neurodegenerative diseases. ADAM17 is upregulated in both diabetes and Alzheimer's disease,suggesting a shared mechanism and implicating inflammation as a possible contributor to muchbroader forms of pathology and pointing to a possible link between inflammation and the emergenceof MCI. This review provides an overview of the different roles of ADAM17 in diabetes-associatedmild cognitive impairment diseases. It identifies mechanistic connections through which ADAM17and associated pathways may influence the emergence of mild cognitive impairment. 
    more » « less
  5. Background:Mild cognitive impairment (MCI) can be an early sign of Alzheimer’s disease and other types of dementia detectable through gait analysis. Curve walking, which demands greater cognitive and motor skills, may be more sensitive in MCI detection than straight walking. However, few studies have compared gait performance in older adults with and without MCI in these conditions. Objective:To compare the capability of curve and straight walking tests for the detection of MCI among older adults. Methods:We employed a Kinect v.2 camera to record the gait of 55 older adults (30 healthy controls, 25 with MCI) during single-task straight and curve walking tests. We examined 50 gait markers and conducted statistical analyses to compare groups and conditions. The trail was approved with protocol No. IR.SEMUMS.REC.1398.237 by the ethics committee of Semnan University of Medical Sciences in Iran. Results:Older adults with MCI exhibited more compromised gait performance, particularly during curve walking. Curve walking outperformed straight walking in MCI detection, with several gait markers showing significant differences between healthy controls and MCI patients. These markers encompass average velocity, cadence, temporal markers (e.g., gait cycle subphase durations), spatial markers (e.g., foot position changes during gait subphases), and spatiotemporal markers (e.g., step and stride velocities). Conclusions:Our study suggests curve walking as a more informative and challenging test for MCI detection among older adults, facilitating early diagnosis using non-invasive, cost-effective tools like the Kinect v.2 camera, complementing cognitive assessments in early diagnosis, and tracking MCI progression to dementia. 
    more » « less